Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-01

Clinical Trial Update: To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pregabalin for painful diabetic neuropathy has completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED